University of Chicago Medicine
Chicago, Illinois
David T. Rubin, MD, FACG, AGAF, FACP, FASGE, FRCP (Edinburgh)
Joseph B. Kirsner Professor of Medicine; Professor of Medicine
Chief, Section of Gastroenterology, Hepatology and Nutrition; University of Chicago Medicine, Chicago, IL
David T. Rubin is the Joseph B. Kirsner Professor of Medicine, Chief of the Section of Gastroenterology, Hepatology & Nutrition at the University of Chicago Medicine. He earned a medical degree with honors at The University of Chicago Pritzker School of Medicine where he also completed his residency in internal medicine and fellowships in gastroenterology and clinical medical ethics. He is associate faculty member at the MacLean Center for Clinical Medical Ethics, associate investigator at the University of Chicago Comprehensive Cancer Center and a member of the University of Chicago Committee on Clinical Pharmacology and Pharmacogenomics. He is the chair of the National Scientific Advisory Committee of the Crohn’s & Colitis Foundation. He is the deputy chair of the Executive Committee of the International Organization for the Study of Inflammatory Bowel Disease.
Dr. Rubin twice received the ACG’s Governor’s Award of Excellence in Clinical Research (2003 and 2013), and in 2020, Dr. Rubin received the Sherman Prize for Excellence in Crohn’s and Colitis. He is an Associate Editor of the journal Gastroenterology and Editor-in-Chief of the ACG On-Line Education Universe. Dr. Rubin is an editor of Curbside Consultation in IBD (3rd ed), senior editor of Sleisenger and Fordtran’s Gastrointestinal and Liver Disease (12th ed), and an author on >500 articles on management of IBD, including the 2019 ACG Guidelines for ulcerative colitis. He has a verified Twitter account @IBDMD with over 20,500 followers.
Disclosure information not submitted.
Session IV: Special Situations in UC
Saturday, April 1, 2023
8:15 AM – 9:00 AM .
Dysplasia in IBD: Best Practices
Saturday, April 1, 2023
8:30 AM – 8:45 AM .
Saturday, April 1, 2023
8:45 AM – 9:00 AM .
Session VII: Utilizing our Therapeutic Armamentarium: Right Patient/Right Drug
Saturday, April 1, 2023
12:15 PM – 1:00 PM .
JAK Inhibitors: Efficacy and Safety
Saturday, April 1, 2023
12:15 PM – 12:30 PM .
Session IV: Special Situations in UC
Friday, April 21, 2023
8:15 AM – 9:00 AM .
Dysplasia in IBD: Best Practices
Friday, April 21, 2023
8:30 AM – 8:45 AM .
Friday, April 21, 2023
8:45 AM – 9:00 AM .
Session VII: Utilizing our Therapeutic Armamentarium: Right Patient/Right Drug
Friday, April 21, 2023
12:30 PM – 1:15 PM .
JAK Inhibitors: Efficacy and Safety
Friday, April 21, 2023
12:30 PM – 12:45 PM .
Session IV: Special Situations in UC
Friday, June 16, 2023
8:00 AM – 8:45 AM .
Dysplasia in IBD: Best Practices
Friday, June 16, 2023
8:15 AM – 8:30 AM .
Session V: Utilizing our Therapeutic Armamentarium: Right Patient/Right Drug
Friday, June 16, 2023
9:00 AM – 10:00 AM .
Small But Mighty: JAK Inhibitors
Friday, June 16, 2023
9:00 AM – 9:15 AM .
Session V - Utilizing our Therapeutic Armamentarium: Right Patient/Right Drug
Saturday, July 22, 2023
9:15 AM – 10:30 AM .
Small But Mighty: JAK Inhibitors
Saturday, July 22, 2023
9:15 AM – 9:35 AM .
Session IV: Special Situations in UC
Friday, August 18, 2023
8:00 AM – 8:45 AM .
Session V: Utilizing our Therapeutic Armamentarium: Right Patient/Right Drug
Friday, August 18, 2023
9:00 AM – 10:00 AM .
Session IV: Special Situations in UC
Friday, September 15, 2023
8:00 AM – 8:45 AM .
Dysplasia in IBD: Best Practices
Friday, September 15, 2023
8:15 AM – 8:30 AM .
Session V: Utilizing our Therapeutic Armamentarium: Right Patient/Right Drug
Friday, September 15, 2023
9:00 AM – 10:00 AM .
Small But Mighty: JAK Inhibitors
Friday, September 15, 2023
9:00 AM – 9:15 AM .